The Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is rated a Buy due to its flexible structure and attractive valuation, currently trading at about a 9.5% discount to its net asset value (NAV). The fund employs an option strategy targeting 35–75% coverage, now around 60%, focusing on income generation through aggressive call writing without spreads. It offers a roughly 9% yield with tax-efficient distributions, mostly long-term capital gains, and has an expense ratio near 0.97%. Given expectations of rangebound markets, SPXX's income-focused approach and discount provide a compelling opportunity for investors seeking steady income and risk management.
The Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is currently trading at about a 9.5% discount to its net asset value, offering a roughly 9% yield. For readers following US stocks on Pluang, here is the market snapshot as of Sep 18, 2026 03:42 WIB: out of 150 priced US stocks, 103 rose and 46 fell. Notable movers include DraftKings Inc (DKNG) at USD 22.52 with a -7.44% change and balanced buy/sell orders, Novavax Inc (NVAX) at USD 10.03 up 7.22% with all buy orders, and Fubotv Inc (FUBO) at USD 9.90 down 6.60% with predominantly sell orders.
BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...
Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...
Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
